| Daniel Loran Jensen, DO | |
|
27500 Hoover Rd, Ste 100, Warren, MI 48093-4586 | |
| (586) 754-2558 | |
| Not Available |
| Full Name | Daniel Loran Jensen |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 24 Years |
| Location | 27500 Hoover Rd, Warren, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326230236 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 5101015155 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Macomb Oakland Hosp-warren Campus | Warren, MI | Hospital |
| Entity Name | Daniel L Jensen D O P L L C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619242179 PECOS PAC ID: 6305009499 Enrollment ID: O20120530000431 |
News Archive
Resolvin E1, a molecule produced naturally in the body from an omega -3 fish oil, topically applied on gum tissues not only prevents and treats gum disease as previously shown (Hasturk et al 2006 and 2007), but also decreases the likelihood for advanced arterial atherosclerotic plaques to rupture and form a dangerous thrombus or blood clot.
Clorox Healthcare will be among the stakeholders participating in a White House Forum tomorrow in support of ongoing public and private efforts to reduce healthcare-associated infections (HAIs), many of which are caused by multidrug-resistant organisms (MDROs).
BioCryst Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of treatments for rare and infectious diseases, today announced that it has submitted a New Drug Application (NDA) filing for intravenous (i.v.) peramivir to the U.S. Food & Drug Administration (FDA). BioCryst is seeking an indication as the first i.v. neuraminidase inhibitor approved in the U.S. for the treatment of acute uncomplicated influenza in adults. Peramivir is approved in Japan and Korea for the treatment of influenza.
Low-income Louisiana patients enrolled in a tailored obesity intervention program lost much more weight than counterparts receiving usual care. Study results were published this week in The New England Journal of Medicine.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Loran Jensen, DO Po Box 6739195, Detroit, MI 48267-3937 Ph: (810) 720-5715 | Daniel Loran Jensen, DO 27500 Hoover Rd, Ste 100, Warren, MI 48093-4586 Ph: (586) 754-2558 |
News Archive
Resolvin E1, a molecule produced naturally in the body from an omega -3 fish oil, topically applied on gum tissues not only prevents and treats gum disease as previously shown (Hasturk et al 2006 and 2007), but also decreases the likelihood for advanced arterial atherosclerotic plaques to rupture and form a dangerous thrombus or blood clot.
Clorox Healthcare will be among the stakeholders participating in a White House Forum tomorrow in support of ongoing public and private efforts to reduce healthcare-associated infections (HAIs), many of which are caused by multidrug-resistant organisms (MDROs).
BioCryst Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of treatments for rare and infectious diseases, today announced that it has submitted a New Drug Application (NDA) filing for intravenous (i.v.) peramivir to the U.S. Food & Drug Administration (FDA). BioCryst is seeking an indication as the first i.v. neuraminidase inhibitor approved in the U.S. for the treatment of acute uncomplicated influenza in adults. Peramivir is approved in Japan and Korea for the treatment of influenza.
Low-income Louisiana patients enrolled in a tailored obesity intervention program lost much more weight than counterparts receiving usual care. Study results were published this week in The New England Journal of Medicine.
› Verified 5 days ago
Dr. Edwin V Wehling, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 13355 E 10 Mile Rd, Warren, MI 48089 Phone: 586-759-7300 | |
Martin Quiroga, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 27101 Schoenherr Rd Ste 200, Warren, MI 48088 Phone: 586-806-6466 Fax: 586-806-6395 | |
Dr. Frederick Scott Nichols, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 27472 Schoenherr Rd, Ste #150, Warren, MI 48088 Phone: 586-393-7777 Fax: 586-777-1533 | |
Dr. Zena G Yousif, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 11012 E 13 Mile Rd, Suite 112, Warren, MI 48093 Phone: 586-573-6880 Fax: 586-751-0950 | |
Dr. Jeremy Ryan Ciullo, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 11012 E 13 Mile Rd Ste 112, Warren, MI 48093 Phone: 586-573-5880 Fax: 586-573-2562 | |
Dr. Anthony A Adeleye, MD Surgery Medicare: Medicare Enrolled Practice Location: 30838 Schoenherr Rd, Warren, MI 48088 Phone: 586-944-2115 Fax: 586-777-1031 | |
John Jerius, MD Surgery Medicare: Medicare Enrolled Practice Location: 27150 Ryan Rd, Warren, MI 48092 Phone: 586-693-3821 |